|
|
||||||||

*
Department of Medicine, Laval University Heart and Lung Institute, Laval Hospital, Ste-Foy, Quebec, Canada; and
Department of Medicine, Pulmonary Research Group, University of Alberta, Edmonton, Alberta, Canada
Histamine, a well-known inflammatory mediator, has been implicated
in various immunoregulatory effects that are poorly understood. Thus,
we tested the hypothesis that histamine inhibits the release of a
proinflammatory cytokine, namely TNF, by stimulating the release of an
anti-inflammatory cytokine, IL-10. Alveolar macrophages (AMs) from
humans, Sprague Dawley rats, and the AM cell line, NR8383, were treated
with different concentrations of histamine
(10-5-10-7 M) for 2 h prior to their
stimulation with suboptimal concentration of LPS (1 ng/ml) for 4
h. Histamine inhibited TNF release in a dose-dependent manner. This
inhibition was mimicked by H2 and H3 receptor
agonists, but not by H1 receptor agonist. Furthermore, we
demonstrated the expression of H3 receptor mRNA in human
AMs. Interestingly, treatment of AMs with anti-IL-10,
anti-PGE2, or a NO synthase inhibitor
(N
-nitro-L-arginine methyl
ester) before the addition of histamine abrogated the inhibitory effect
of the latter on TNF release. Histamine treatment (10-5 M)
increased the release of IL-10 from unstimulated (2.2-fold) and
LPS-stimulated (1.7-fold) AMs. Unstimulated AMs, NR8383, express few
copies of IL-10 mRNA, as tested by quantitative PCR, but expression of
IL-10 was increased by 1.5-fold with histamine treatment. Moreover, the
stimulation of IL-10 release by histamine was abrogated by pretreatment
with anti-PGE2 or the NO synthase inhibitor,
N
-nitro-L-arginine methyl ester. Thus,
histamine increases the synthesis and release of IL-10 from AMs through
PGE2 and NO production. These results suggest that
histamine may play an important role in the modulation of the cytokine
network.
This article has been cited by other articles:
![]() |
M. M. Amaral, C. Davio, A. Ceballos, G. Salamone, C. Canones, J. Geffner, and M. Vermeulen Histamine Improves Antigen Uptake and Cross-Presentation by Dendritic Cells J. Immunol., September 15, 2007; 179(6): 3425 - 3433. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. H. Mauban, K. Wilkinson, C. Schach, and J. X.-J. Yuan Histamine-mediated increases in cytosolic [Ca2+] involve different mechanisms in human pulmonary artery smooth muscle and endothelial cells Am J Physiol Cell Physiol, February 1, 2006; 290(2): C325 - C336. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Cianchi, C. Cortesini, N. Schiavone, F. Perna, L. Magnelli, E. Fanti, D. Bani, L. Messerini, V. Fabbroni, G. Perigli, et al. The Role of Cyclooxygenase-2 in Mediating the Effects of Histamine on Cell Proliferation and Vascular Endothelial Growth Factor Production in Colorectal Cancer Clin. Cancer Res., October 1, 2005; 11(19): 6807 - 6815. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Masaki, S. Chiba, H. Tatsukawa, H. Noguchi, T. Kakuma, M. Endo, M. Seike, T. Watanabe, and H. Yoshimatsu The role of histamine H1 receptor and H2 receptor in LPS-induced liver injury FASEB J, August 1, 2005; 19(10): 1245 - 1252. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-I. Proulx, A. Castonguay, and E. Y. Bissonnette Cytokine production by alveolar macrophages is down regulated by the {alpha}-methylhydroxylation pathway of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) Carcinogenesis, June 1, 2004; 25(6): 997 - 1003. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Nemmar, B. Nemery, P. H. M. Hoet, J. Vermylen, and M. F. Hoylaerts Pulmonary Inflammation and Thrombogenicity Caused by Diesel Particles in Hamsters: Role of Histamine Am. J. Respir. Crit. Care Med., December 1, 2003; 168(11): 1366 - 1372. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Nemmar, P. H.M. Hoet, D. Dinsdale, J. Vermylen, M. F. Hoylaerts, and B. Nemery Diesel Exhaust Particles in Lung Acutely Enhance Experimental Peripheral Thrombosis Circulation, March 4, 2003; 107(8): 1202 - 1208. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Gantner, K. Sakai, M. W. Tusche, W. W. Cruikshank, D. M. Center, and K. B. Bacon Histamine H4 and H2 Receptors Control Histamine-Induced Interleukin-16 Release from Human CD8+ T Cells J. Pharmacol. Exp. Ther., October 1, 2002; 303(1): 300 - 307. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Liu, S. J. Wilson, C. Kuei, and T. W. Lovenberg Comparison of Human, Mouse, Rat, and Guinea Pig Histamine H4 Receptors Reveals Substantial Pharmacological Species Variation J. Pharmacol. Exp. Ther., October 1, 2001; 299(1): 121 - 130. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Caron, Y. Delneste, E. Roelandts, C. Duez, N. Herbault, G. Magistrelli, J.-Y. Bonnefoy, J. Pestel, and P. Jeannin Histamine Induces CD86 Expression and Chemokine Production by Human Immature Dendritic Cells J. Immunol., May 15, 2001; 166(10): 6000 - 6006. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Triggiani, M. Gentile, A. Secondo, F. Granata, A. Oriente, M. Taglialatela, L. Annunziato, and G. Marone Histamine Induces Exocytosis and IL-6 Production from Human Lung Macrophages Through Interaction with H1 Receptors J. Immunol., March 15, 2001; 166(6): 4083 - 4091. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhu, D. Michalovich, H.-L. Wu, K. B. Tan, G. M. Dytko, I. J. Mannan, R. Boyce, J. Alston, L. A Tierney, X. Li, et al. Cloning, Expression, and Pharmacological Characterization of a Novel Human Histamine Receptor Mol. Pharmacol., March 1, 2001; 59(3): 434 - 441. [Abstract] [Full Text] |
||||
![]() |
G. Ménard and E. Y. Bissonnette Priming of Alveolar Macrophages by Leukotriene D4 . Potentiation of Inflammation Am. J. Respir. Cell Mol. Biol., October 1, 2000; 23(4): 572 - 577. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |